Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Ambrisentan
(Letairis (TN))		1件: Ambrisentan (Letairis)1件: Ambrisentan (Letairis (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 51, 84, 85, 86, 88, 210, 211 💬
2Ambrisentan - high dose
(Letairis (TN))		1件: Ambrisentan (Letairis)1件: Ambrisentan (Letairis (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
3Ambrisentan - low dose
(Letairis (TN))		1件: Ambrisentan (Letairis)1件: Ambrisentan (Letairis (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
4Ambrisentan 5 mg
(Letairis (TN))		1件: Ambrisentan (Letairis)1件: Ambrisentan (Letairis (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 88 💬
5Ambrisentan 5 mg film-coated tablets
(Letairis (TN))		1件: Ambrisentan (Letairis)1件: Ambrisentan (Letairis (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
6Ambrisentan 5mg film-coated tablets [marketed product]
(Letairis (TN))		1件: Ambrisentan (Letairis)1件: Ambrisentan (Letairis (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
7Ambrisentan plus Spironolactone
(Letairis (TN))		2件: Ambrisentan (Letairis),
Spironolactone		2件: Spironolactone ,
Ambrisentan (Letairis (TN)) 💬		2件: EDNRA,
NR3C2 💬		8件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
8Ambrisentan Tablet
(Letairis (TN))		1件: Ambrisentan (Letairis)1件: Ambrisentan (Letairis (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
9Bosentan, Ambrisentan
(Letairis (TN))		2件: Ambrisentan (Letairis),
Bosentan		3件: Bosentan ,
Ambrisentan (Letairis (TN)),
Bosentan 💬		2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
10Letairis1件: Ambrisentan (Letairis)1件: Ambrisentan (Letairis (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
11Letairis 10 mg1件: Ambrisentan (Letairis)1件: Ambrisentan (Letairis (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
12Letairis 5 mg1件: Ambrisentan (Letairis)1件: Ambrisentan (Letairis (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
13Tadalafil and ambrisentan upfront combination therapy
(Letairis (TN))		2件: Ambrisentan (Letairis),
Tadalafil		2件: Tadalafil ,
Ambrisentan (Letairis (TN)) 💬		2件: EDNRA,
PDE5A 💬		9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
14VOLIBRIS® (ambrisentan)
(Letairis (TN))		1件: Ambrisentan (Letairis)1件: Ambrisentan (Letairis (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬